A Case of Acute Mania and Rhabdomyolysis Associated With Long-Term, Daily Psilocybin Use

Paper. Wells DA, Hayes L, Walker K. Journal of Clinical Psychopharmacology, 21 Sep 2026.

Tags: Psilocybin.

Weekly Science Digest, 19 Sep 2026 to 25 Sep 2026, finding 1: A population trials usually exclude

Psilocybin was tolerated in 14 people with bipolar II depression, with no mania reported.

The open-label, single-arm trial started at 10 mg and escalated to 25 mg if symptoms persisted, with therapy around each session. Cardiovascular changes were transient; the primary depression endpoint came 21 days after the final dose.

Read the original

—
Node—
Statuslive
Throughput—